ArticleNature reviews. Clinical oncology2022
SBRT feasible for oligometastatic RCC.
Peter SidawayPubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleNature reviews. Clinical oncology2022
Peter SidawayPubMed ↗Publisher ↗
No numbers read from the abstract.